Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew McLean-Tooke

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
BMJ Case Reports|September 25, 2012
Sulphadiazine-induced renal stones in a 63-year-old HIV-infected man treated for toxoplasmosisBenjamin David McGettigan, Meilyn Hew, Elizabeth Phillips, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 1, 2020
Vedolizumab is safe and effective in the treatment of X-linked agammaglobulinemia-associated inflammatory bowel diseaseJovanka R King, Zubin Grover, Nazneen Irani, et al.
Chest|March 10, 2018
Sjögren Syndrome With Associated Lymphocytic Interstitial Pneumonia Successfully Treated With Tacrolimus and Abatacept as an Alternative to RituximabGrace Thompson, Andrew Mclean-Tooke, Jeremy Wrobel, et al.
Journal of Clinical Pathology|August 14, 2013
Postmortem serum tryptase levels in anaphylactic and non-anaphylactic deathsAndrew McLean-Tooke, Mark Goulding, Christine Bundell, et al.
The Journal of Allergy and Clinical Immunology|May 20, 2008
Immunologic defects in 22q11.2 deletion syndromeAndrew McLean-Tooke, Dawn Barge, Gavin P Spickett, et al.
Pathology|December 8, 2024
Diagnostic performance of assays for urgent MPO, PR3 and GBM autoantibodies in suspected vasculitisAndrew McLean-Tooke, Joanne Ong, Alexandra Kwan, et al.
Frontiers in Immunology|August 12, 2025
VEXAS: A review of current understandings and emerging treatment strategiesRobert Holden, Yogeshraj Jeelal, Andrew McLean-Tooke, et al.
Frontiers in Immunology|March 16, 2026
Correction: VEXAS: A review of current understandings and emerging treatment strategiesRobert Holden, Yogeshraj Jeelall, Andrew McLean-Tooke, et al.
Rheumatology (Oxford, England)|May 19, 2009
Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?Andrew McLean-Tooke, Catherine Aldridge, Sheila Waugh, et al.
Annals of Clinical Biochemistry|January 12, 2021
Calculated globulin as a screening tool for hypogammaglobulinaemia or paraproteins in hospitalized patientsTeng Hoo, Ee Mun Lim, Mina John, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
BMJ Case Reports|September 25, 2012
Sulphadiazine-induced renal stones in a 63-year-old HIV-infected man treated for toxoplasmosisBenjamin David McGettigan, Meilyn Hew, Elizabeth Phillips, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 1, 2020
Vedolizumab is safe and effective in the treatment of X-linked agammaglobulinemia-associated inflammatory bowel diseaseJovanka R King, Zubin Grover, Nazneen Irani, et al.
Chest|March 10, 2018
Sjögren Syndrome With Associated Lymphocytic Interstitial Pneumonia Successfully Treated With Tacrolimus and Abatacept as an Alternative to RituximabGrace Thompson, Andrew Mclean-Tooke, Jeremy Wrobel, et al.
Journal of Clinical Pathology|August 14, 2013
Postmortem serum tryptase levels in anaphylactic and non-anaphylactic deathsAndrew McLean-Tooke, Mark Goulding, Christine Bundell, et al.
The Journal of Allergy and Clinical Immunology|May 20, 2008
Immunologic defects in 22q11.2 deletion syndromeAndrew McLean-Tooke, Dawn Barge, Gavin P Spickett, et al.
Pathology|December 8, 2024
Diagnostic performance of assays for urgent MPO, PR3 and GBM autoantibodies in suspected vasculitisAndrew McLean-Tooke, Joanne Ong, Alexandra Kwan, et al.
Frontiers in Immunology|August 12, 2025
VEXAS: A review of current understandings and emerging treatment strategiesRobert Holden, Yogeshraj Jeelal, Andrew McLean-Tooke, et al.
Frontiers in Immunology|March 16, 2026
Correction: VEXAS: A review of current understandings and emerging treatment strategiesRobert Holden, Yogeshraj Jeelall, Andrew McLean-Tooke, et al.
Rheumatology (Oxford, England)|May 19, 2009
Methotrexate, rheumatoid arthritis and infection risk: what is the evidence?Andrew McLean-Tooke, Catherine Aldridge, Sheila Waugh, et al.
Annals of Clinical Biochemistry|January 12, 2021
Calculated globulin as a screening tool for hypogammaglobulinaemia or paraproteins in hospitalized patientsTeng Hoo, Ee Mun Lim, Mina John, et al.
Pageof 6